Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07530276) titled 'A Prospective Observational Study of Changes in Cortisol Levels After Neoadjuvant Immunotherapy and Their Prognostic Value in Patients With NSCLC' on April 8.

Study Type: Observational [Patient Registry]

Primary Sponsor: Guangdong Provincial People's Hospital

Condition: NSCLC

Recruitment Status: Not recruiting

Date of First Enrollment: August 30, 2024

Target Sample Size: 330

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07530276

Disclaimer: Curated by HT Syndication....